Pancreatic metabolism, blood flow, and β-Cell function in obese humans

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 6, 2014, Pages

  Honka, Henri ^a   Hannukainen, Jarna C ^a   Tarkia, Miikka ^a   Karlsson, Henry ^a   Saunavaara, Virva ^a   Salminen, Paulina ^b   Soinio, Minna ^c   Mikkola, Kirsi ^a   Kudomi, Nobu ^d   Oikonen, Vesa ^a   Haaparanta Solin, Merja ^a   Roivainen, Anne ^a   Parkkola, Riitta ^a,e   Iozzo, Patricia ^f,g   Nuutila, Pirjo ^a,c  

^a TURKU PET CENTRE   (Finland)

^b Division of Digestive Surgery and Urology   (United States)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d KAGAWA UNIVERSITY   (Japan)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^f CNR   (Italy)

^g INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

14 FLUORO 6 THIA HEPTADECANOIC ACID F 18; FATTY ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENERGY METABOLISM; EX VIVO STUDY; FAT CONTENT; FATTY ACID TRANSPORT; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; IN VIVO STUDY; INSTRUMENT VALIDATION; INSULIN RESISTANCE; LIPID STORAGE; MAJOR CLINICAL STUDY; METABOLISM; MORBID OBESITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BLOOD FLOW; PANCREAS ISLET CELL FUNCTION; PANCREATIC METABOLISM; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; ANIMALS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; MIDDLE AGED; OBESITY, MORBID; PANCREAS; REGIONAL BLOOD FLOW; SWINE;

EID: 84902312418     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4369     Document Type: Article

References (40)

1. Lin Y, Sun Z. Current views on type 2 diabetes. J Endocrinol. 2010; 204:1-11.
2. Heni M, Machann J, Staiger H, et al. Pancreatic fat is neg atively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200-205.
3. Lingvay I , Esser V, Legendre JL, et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab. 2009;94:4070-4076.
4. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and-cell function in men with and without type 2 diabetes. Diabetes Care. 2007;30:2916-2921.
5. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic-cells. Diabetologia. 2003;46:1297-1312.
6. Mari A, Tura A, Natali A, Laville M, et al. Impa ired-cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia. 2010;53:749-756.
7. Kwon G, Marshall CA, Pappan KL, Remedi MS, McDaniel ML. Signaling elements involved in the metabolic regulation ofmTORby nutrients, incretins, and growth factors in islets. Diabetes. 2004; 53(suppl 3):S225-S232.
8. Solomon TP, K nudsen SH, Karstoft K, Winding K, Holst JJ, Pedersen BK. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity. J Clin Endocrinol Metab. 2012;97:468 2-4691.
9. Lau J, Svensson J, Grapensparr L, Johansson A, Carlsson PO. Superior-cell proliferation, function and gene expression in a subpopulation of rat islets identified by high blood perfusion. Diabetologia. 2012 ;55:1390-1399.
10. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metab Rev. 1994;10:407-416.
11. Tsushima Y, Miyazaki M, Taketomi-Takahashi A, Endo K. Feasibility of measuring human pancreatic perfusion in vivo using imaging techniques. Pancreas. 2011;40:747-752.
12. Honka H, Mäkinen J, Hannukainen JC, et al. Validation of [18 F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity. Diabetologia. 2013;56:893-900.
13. HelmiöM, Victorzon M, Ovaska J, et al. SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc. 2012;26:2521-2526.
14. Nuutila P,Koivisto VA,Knuuti J,et al Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo J Clin Invest. 1992 89 1767-1774.
15. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
16. Liukk o KE, Oikonen VJ, Tolvanen TK, et al. Non-invasive estimation of subcutaneous and visceral adipose tissue blood flow by using (15O)H2O PET with image derived input functions. Open Med Imaging J. 2007;1:7-13.
17. Iozzo P, Turpeinen AK, Takala T, et al. Liver uptake of free fatty acids in vivo in humans as determined with 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid and PET. Eur J Nucl Med Mol Imaging. 2003;30: 1160-1164.
18. Karmi A, Iozzo P, Viljanen A, et al. Increased brain fatty acid uptake in metabolic syndrome. Diabetes. 2010;59:2171-2177.
19. Germano G, Chen BC, H uang SC, Gambhir SS, Hoffman EJ, Phelps ME. Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med. 1992;33: 613-620.
20. Haaparanta M, Paul R, Gr önroos T, Bergman J, Kamarainen EL, Solin O. Microdialysis and 2-[18F]fluoro-2-deoxy-D-glucose (FDG): a study on insulin action on FDG transport, uptake and metabolism in rat muscle, live r and adipose tissue. Life Sci. 2003;73:1437-1451.
21. Kraegen EW, James DE, Jenkins AB, Chisholm DJ. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats.AmJ Physiol. 1985;248:E353-E362.
22. Ishizu K, Nishizawa S, Yonekura Y, et al. Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med. 1994;35: 1104-1109.
23. Thie JA. Clarification of a fractional uptake concept. J Nucl Med. 1995;36:711-712.
24. Peltoniemi P, Lonnroth P, Laine H, et al. Lumped constant for [18F]fluorodeoxyglucose i n skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab. 2000;279:E1122-1130.
25. Kety SS, Schmidt CF. Measurement of cerebral blood flow and cerebral oxygen consumption in man. Fed Proc. 1946;5:264.
26. Kudomi N, Slimani L, Järvisalo MJ, et al. Non-invasive estimation of hepatic blood perfusion from H2 15O PET images using tissuederived arterial and portal input functions. Eur J Nucl Med Mol Imaging. 2008;35:1899-1911.
27. Schwenzer NF, Machann J, Martirosian P, et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase a nd spectral-spatial excitation techniques. Invest Radiol. 2008;43:330-337.
28. Silvola JM, Saraste A, Laitinen I, et al. Effects of age, diet, and type 2 diabetes on the development and FDG uptak e of atherosclerotic plaques. JACC Cardiovasc Imaging. 2011;4:1294-1301.
29. Reinert RB, Brissova M, Shostak A, et al. Vascular endothelial growth factor-A and islet vascularization are necessary in developing, but not adult, pancreatic islets. Diabetes. 2013;62:4154-4164.
30. Ota H, Tamaki S, Itaya-Hironaka A, et al. Attenuation of glucoseinduced insulin secretion by intermittent hypoxia via down-regulation of CD38. Life Sci. 2012;90:206-211.
31. Dai C, Brissova M, Reinert RB, et al. Pancreatic islet vasculature adapts to insulin resistance through dilation and not angiogenesis. Diabetes. 2013;62:4144-4153.
32. Jansson L, Ande rsson A, Bodin B, Kallskog O. Pancreatic islet blood flow during euglycaemic, hyperinsulinaemic clamp in anaesthetized rats. Acta Physiol (Oxf). 2007;189:319-324.
33. Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE. Diabetes and apoptosis: lipotoxicity. Apoptosis. 2009;14:1484-1495.
34. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933-942.
35. Labbé SM,Croteau E,Grenier-Larouche T,et al Normal postprandia l nonesterified fatty acid uptake in muscles despite increased circulating fatty acids in type 2 diabetes Diabetes. 2011 60 408-415.
36. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest. 1994;93:870-876.
37. Wallin T, Ma Z, Ogata H, et al. Facilitation of fatty acid uptake by CD36 in insulin-producing cells reduces fatty-acid-induced insulin secretion and glucose regulation of fatty acid oxidation. Biochim Biophys Acta. 2010;1801:191-197.
38. Bajaj M, Pratipan awatr T, Berria R, et al. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes. Diabetes. 2002;51:3043-3048.
39. Hyder A, Zenhom M, Klapper M, Herrmann J, Schrezenmeir J. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose. Islets. 2010;2:174-184.
40. Kim YW, Moon JS, Seo YJ, et al. Inhibition of fatty acid translocase cluster determinant 36 (CD36), stimulated by hyperglycemia, prevents glucotoxicity in INS-1 cells. Biochem Biophys Res Commun. 2012;420:462-466.